The sandbox: Parker Institute throws its research muscle behind gene therapy tech for destroying cancer cells
A fantastic article in Endpoint News about the collaboration between PsiOxus and the Parker Institute for Cancer Immunotherapy.
Recent Posts
- PsiOxus Therapeutics Announces First-in-Human Dosing of their Second Gene Therapy Cancer Treatment.
- PsiOxus Therapeutics to Collaborate with the Parker Institute for Cancer Immunotherapy
- PsiOxus Therapeutics Appoints Melissa Epperly as Chief Financial Officer
- PsiOxus Therapeutics Receives $15 Million Milestone Payment as Armed Oncolytic Virus Licensed to Bristol-Myers Squibb Achieves CTA
- PsiOxus Therapeutics is listed in FierceBiotech’s 2017 Fierce 15
Comments are closed.